
The US Oncology Network
Shaping the future of cancer care, close to home.
It’s an unprecedented time for patients living with cancer and other chronic illnesses as life sciences companies race to create new, cutting-edge therapies, and patients struggle to navigate the challenges and complexity of their care.
As a leading distributor of oncology and specialty medicines, we provide end-to-end services across the drug lifecycle and ensure therapies make their way to those who are counting on them.
Our portfolio of oncology solutions aims to address hurdles throughout every stage of the clinical process and improve outcomes by accelerating drug development and clinical trial activation, expanding access to cancer care closer to home and delivering real-world data and
evidence to advance care.
Shaping the future of cancer care, close to home.
Harnessing technology and insights to transform the fight against cancer.
Advancing the field of cancer research together.
Providing market data and insights.
Caring for patients with cancer and rare diseases.
Maximizing contract savings for specialty practices.
Innovating precision medicine to improve patient outcomes by enabling clinical trial matching.
Helping specialty providers run successful businesses by clearing the path so they can focus on patient care.
Bridging the gap between cell and gene therapy innovation and reality.
Leading outpatient infusion management.
Simplifying clinical trial logistics.
Enabling medication access and affordability.
As the #1 distributor of oncology, rheumatology and gastroenterology products, we offer the expertise to manage through logistical challenges like cold chain requirements, regulatory compliance, dispensing support and more.
We offer expertise that physicians can rely on to support critical treatment options.
15%
Practices in The US Oncology Network treat over 15% of all new cancer patients each year, bringing high-quality care to anyone facing a diagnosis.
1k+
Through SCRI, we are actively enrolling patients to more than 1,000 cancer-focused trials each year.
80k+
We’ve supported over 80,000 patients in more than 1,600 clinical trials.
200+
We offer hundreds of oncology and rare disease therapies — some exclusively — to treat cancer and its side effects.
Today, one in two men and one in three women will be diagnosed with cancer during their lifetime. That’s why together with our partners, we offer research, insights, technologies and services that assist providers and biopharma companies in navigating the intricacies of advancing cancer care.
We provide oncology and specialty support across the healthcare spectrum.
We partner with biopharma to accelerate oncology innovation — every step of the way. See how our connected businesses support the drug development lifecycle and the patient care experience. From discovery and clinical trials to treatment access, real-world insights and survivorship, we help bring therapies to market faster and support providers in delivering personalized care that improves outcomes for patients.
Discover our oncology and specialty stories, from business insights to employee spotlights and more.
Check out the latest news covering our expanding footprint, newest FDA approvals, research results and more.